China Digest: Cell therapy developer Neukio bags $50m; Healthcare IT firm Palline closes A+ round
Shanghai-based Neukio's funding round was led by CD Capital
Source: dealstreetasia.com
Surplus Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Surplus Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Surplus Capital Today - Breaking & Trending Today
Neukio Biotherapeutics Closes $50M Series A-1 Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Biocytogen Stages $60 Million IPO
Using its animal models, Biocytogen has also developed an innovative in vivo drug efficacy and safety screening process to discover 10+ preclinical and clinical candidates.
Source: seekingalpha.com
Neukio Biotherapeutics completes financing round for cell therapy products
Neukio Biotherapeutics, a Chinese company committed to developing novel cell therapy products, has closed $50M in a series A-1 funding round.
Source: labiotech.eu
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products
/PRNewswire/ -- Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces it has closed $50 million in a Series A-1...
Source: prnewswire.com